<p>On September 9th, Eli Lilly announced the launch of the artificial intelligence and machine learning platform TuneLab, which will provide biotechnology companies access to AI drug discovery models trained on its years of research data. Eli Lilly stated that the AI model being launched includes proprietary data obtained at a cost of over $1 billion</p>

<p>On September 9th, Eli Lilly announced the launch of its artificial intelligence and machine learning platform TuneLab, which will provide biotechnology companies access to AI drug discovery models trained on its years of research data. Eli Lilly stated that the AI model being launched contains proprietary data acquired at a cost of over $1 billion</p>

Eli Lilly launches the TuneLab platform, opening AI drug discovery models to biotechnology companies